KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) Interest Coverage Ratio (2017 - 2026)

Aquestive Therapeutics has reported Interest Coverage Ratio over the past 9 years, most recently at 10.38 for Q4 2025.

  • For Q4 2025, Interest Coverage Ratio fell 112.46% year-over-year to 10.38; the TTM value through Dec 2025 reached 6.39, down 130.94%, while the annual FY2025 figure was 6.39, 130.94% down from the prior year.
  • Interest Coverage Ratio for Q4 2025 was 10.38 at Aquestive Therapeutics, down from 4.13 in the prior quarter.
  • Over five years, Interest Coverage Ratio peaked at 0.02 in Q2 2024 and troughed at 10.38 in Q4 2025.
  • A 5-year average of 4.36 and a median of 3.65 in 2024 define the central range for Interest Coverage Ratio.
  • Biggest five-year swings in Interest Coverage Ratio: soared 100.65% in 2024 and later plummeted 20754.23% in 2025.
  • Year by year, Interest Coverage Ratio stood at 6.69 in 2021, then grew by 2.96% to 6.49 in 2022, then surged by 73.5% to 1.72 in 2023, then plummeted by 183.98% to 4.89 in 2024, then crashed by 112.46% to 10.38 in 2025.
  • Business Quant data shows Interest Coverage Ratio for AQST at 10.38 in Q4 2025, 4.13 in Q3 2025, and 4.09 in Q2 2025.